GO:0006110 regulation of glycolysis: Metabolic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006110 (regulation of glycolysis) describes any biological process that modulates the frequency, rate or extent of glycolysis, the cytosolic conversion of glucose to pyruvate.
• Regulation of glycolysis operates at multiple levels: transcriptional control of glycolytic genes, allosteric feedback by metabolites, and post-translational modification of rate-limiting enzymes such as PKM and PEPCK [3,4].
• The liver is a central hub for glucose metabolism, integrating hormonal and nutritional signals to switch between glycolysis and gluconeogenesis.
• Cancer cells frequently reprogram glycolysis (the Warburg effect), and this rewiring is controlled by transcription factors such as SIX1 and by long non-coding RNAs [3,5].
• Glycolytic activity is not only a metabolic endpoint but also an instructive signal that influences cell fate decisions through Nodal and Wnt signaling.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models enable causal testing of glycolytic regulators in disease and development [2,5].
Description
Glycolysis is the central cytosolic pathway that converts glucose into pyruvate, generating ATP and biosynthetic intermediates. The Gene Ontology term GO:0006110, regulation of glycolysis, captures any process that modulates the frequency, rate or extent of this pathway. Because glycolysis sits at the intersection of energy production, biosynthesis and cell-fate signaling, its regulation is essential for normal physiology and is frequently rewired in disease [1,3]. Understanding how glycolysis is regulated requires integrating transcriptional, post-translational and metabolic signals that act on glycolytic enzymes and their upstream regulators [4,6]. For researchers, GO:0006110 provides a structured framework to annotate genes and pathways that control glycolytic flux. Studies in liver have shown that hormonal and nutritional cues dynamically regulate glycolytic and gluconeogenic enzymes to maintain blood glucose homeostasis. In cancer, transcriptional regulators such as SIX1 drive the Warburg effect by upregulating glycolytic genes, and long non-coding RNAs add another layer of control in hepatocellular carcinoma [3,5]. Beyond metabolism, glycolytic activity can instruct developmental decisions, linking metabolic state to signaling pathways such as Nodal and Wnt. This article synthesizes the QuickGO definition of GO:0006110 with verified literature to outline the mechanisms, key genes, disease relevance and experimental models used to study regulation of glycolysis. It is intended for researchers designing CRISPR screens, metabolic assays or transcriptional studies focused on glycolytic control.
regulation of glycolysis At A Glance
| GO ID | GO:0006110 |
|---|---|
| GO term | regulation of glycolysis |
| Ontology | biological_process |
| Definition | Any process that modulates the frequency, rate or extent of glycolysis. |
| Synonym | regulation of glycolysis involved in cellular glucose homeostasis; regulation of glycolytic process |
| Major function | Controls flux through the glycolytic pathway in response to nutrients, hormones and stress. |
| Key regulatory nodes | Transcriptional regulators (e.g., SIX1), post-translational modifiers (e.g., acetylation of PKM and PEPCK), and long non-coding RNAs [3,4,5]. |
| Physiological context | Central to hepatic glucose homeostasis and adaptive metabolic reprogramming during proliferation [1,6]. |
| Disease relevance | Implicated in cancer drug resistance, hepatocellular carcinoma and developmental signaling [2,5,8]. |
What Is GO:0006110?
GO:0006110 (regulation of glycolysis) is a biological process term defined as any process that modulates the frequency, rate or extent of glycolysis. In practical terms, it includes transcriptional, post-transcriptional, translational and post-translational mechanisms that alter the activity or abundance of glycolytic enzymes, as well as allosteric and metabolic feedback that tunes flux through the pathway [1,4]. It also encompasses signaling events that indirectly change glycolytic capacity, such as adaptive regulation of glucose transport and respiration.
Why Is regulation of glycolysis Important in Cell Biology?
Regulation of glycolysis is fundamental because it determines how cells balance energy production, biosynthetic demand and signaling. In the liver, precise control of glycolysis and gluconeogenesis maintains blood glucose within a narrow range, and its dysregulation contributes to metabolic disease. In proliferating cells and tumors, adaptive regulation of glucose transport and glycolysis supports biomass production, and cancer cells often hijack these mechanisms to sustain growth and resist therapy [2,6]. Moreover, glycolytic activity can act as an instructive developmental signal, influencing germ layer proportions through Nodal and Wnt pathways. Thus, GO:0006110 is a nexus for metabolism, gene regulation and disease biology.
• Maintains systemic glucose homeostasis through liver-centric regulation of glycolysis and gluconeogenesis.
• Supports biosynthetic and energetic demands of proliferating cells via adaptive regulation of glucose transport and glycolysis.
• Drives the Warburg effect in cancer through transcriptional regulators such as SIX1.
• Contributes to drug resistance in bladder urothelial carcinoma via tumor aerobic glycolysis.
• Is modulated by long non-coding RNAs in hepatocellular carcinoma, offering therapeutic targets.
• Involves post-translational control, such as acetylation of PKM and PEPCK, which alters enzyme activity.
• Links metabolic state to developmental signaling, influencing germ layer proportions through Nodal and Wnt.
• Provides a framework for annotating genes that modulate glycolytic flux in health and disease [1,3].
• Enables CRISPR-based causal testing of glycolytic regulators in cancer and metabolic models [2,5].
• Informs therapeutic strategies targeting metabolic reprogramming in oncology and inflammation [2,7].
What Happens During regulation of glycolysis?
Transcriptional control of glycolytic genes
In simple terms: Cells can turn glycolysis up or down by changing how much of each glycolytic enzyme they make.
Transcriptional regulation of glycolysis involves transcription factors that bind promoters or enhancers of glycolytic genes and alter their expression. In cancer, the transcription factor SIX1 drives the Warburg effect by upregulating glycolytic genes, thereby increasing flux through the pathway. In hepatocellular carcinoma, long non-coding RNAs modulate the expression of glycolytic enzymes and related regulators, adding a layer of transcriptional and post-transcriptional control. These mechanisms allow cells to adapt glycolytic capacity to proliferative or metabolic demands.
Post-translational modification of rate-limiting enzymes
In simple terms: Enzymes can be chemically tagged after they are made, which changes how active they are.
Acetylation of key metabolic enzymes such as pyruvate kinase M (PKM) and phosphoenolpyruvate carboxykinase (PEPCK) regulates their activity and stability, thereby influencing glycolytic and gluconeogenic flux. Such post-translational modifications provide rapid, reversible control of glycolysis independent of changes in gene expression. This layer of regulation is critical for matching pathway activity to fluctuating nutrient and hormonal signals.
Allosteric and metabolic feedback
In simple terms: Metabolites themselves can act as signals that speed up or slow down the pathway.
Glycolysis is subject to feedback regulation by intermediates and end-products that allosterically modulate enzyme activity. While the exact allosteric mechanisms vary by enzyme, the overall effect is to balance ATP production with biosynthetic needs. Adaptive regulation of glucose transport, glycolysis and respiration ensures that proliferating cells meet their metabolic requirements. This integration of transport and enzyme activity is a core feature of GO:0006110.
Hormonal and nutritional control in liver
In simple terms: Hormones like insulin and glucagon tell the liver whether to burn or make glucose.
From a liver-centric perspective, regulation of glucose metabolism involves hormonal signals that switch the liver between glycolytic and gluconeogenic modes. Insulin promotes glycolysis and storage, whereas glucagon favors glucose production. This reciprocal regulation maintains blood glucose homeostasis and illustrates how GO:0006110 operates at the organismal level.
Glycolysis as a developmental signal
In simple terms: How fast cells burn sugar can tell them what kind of cell to become.
Glycolytic activity can instruct germ layer proportions through regulation of Nodal and Wnt signaling, demonstrating that metabolic flux is not merely a consequence of cell fate but can actively shape it. This finding expands the functional scope of GO:0006110 beyond energy metabolism to include developmental signaling. It suggests that regulators of glycolysis may have roles in patterning and differentiation.
Key Genes Involved in GO:0006110 regulation of glycolysis
The following genes and proteins are established regulators or effectors of glycolysis, based on the verified literature cited.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SIX1 | Transcription factor driving Warburg effect by upregulating glycolytic genes | Target for cancer metabolism studies and transcriptional regulation of glycolysis |
| PKM | Pyruvate kinase M; rate-limiting glycolytic enzyme regulated by acetylation | Model for post-translational control of glycolysis |
| PEPCK | Phosphoenolpyruvate carboxykinase; gluconeogenic enzyme regulated by acetylation | Studied for reciprocal regulation of glycolysis and gluconeogenesis |
| GPR120 | G-protein coupled receptor influencing colitis via CD4+ T cell IL-10 | Links metabolic signaling to immune regulation |
| Nodal | Developmental signaling pathway instructed by glycolytic activity | Used to study metabolic control of germ layer specification |
| Wnt | Signaling pathway regulated by glycolytic activity | Relevant to developmental and cancer metabolism |
| lncRNAs (various) | Modulate aerobic glycolysis in hepatocellular carcinoma | Potential therapeutic targets and biomarkers |
| Glucose transporters (e.g., GLUT family) | Mediate glucose uptake, a prerequisite for glycolysis | Targets for adaptive regulation studies |
| Hexokinase | First enzyme of glycolysis; often upregulated in cancer | Marker of glycolytic reprogramming |
| PFKFB3 | Regulates fructose-2,6-bisphosphate levels, a potent glycolytic activator | Studied in cancer and inflammation |
| LDHA | Converts pyruvate to lactate, supporting glycolytic flux | Target in drug resistance and tumor metabolism |
| PDK1 | Inhibits pyruvate dehydrogenase, favoring glycolysis | Marker of Warburg effect |
| c-Myc | Transcription factor that can upregulate glycolytic genes | Context-dependent regulator of glycolysis |
| HIF-1alpha | Hypoxia-inducible factor that promotes glycolytic gene expression | Central to tumor aerobic glycolysis |
| AMPK | Energy sensor that can modulate glycolytic flux | Studied in liver glucose metabolism |
| Insulin/Glucagon | Hormonal regulators of hepatic glycolysis and gluconeogenesis | Key to systemic glucose homeostasis |
How Is regulation of glycolysis Regulated?
Regulation of glycolysis is itself controlled by upstream signaling and transcriptional networks. In the liver, insulin and glucagon reciprocally regulate glycolytic and gluconeogenic enzymes to maintain blood glucose. In cancer, transcription factors such as SIX1 and hypoxia-inducible factors drive glycolytic gene expression, while long non-coding RNAs fine-tune pathway activity [3,5]. Post-translational modifications, including acetylation of PKM and PEPCK, provide rapid control. Additionally, glycolytic activity can feed back to developmental signaling pathways such as Nodal and Wnt, creating a regulatory loop between metabolism and cell fate.
regulation of glycolysis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIX1 | Cancer (Warburg effect) | Knockout or overexpression in cancer cell lines |
| LDHA | Bladder urothelial carcinoma drug resistance | Knockout in bladder cancer cells |
| PKM | Metabolic regulation via acetylation | Point-mutation of acetylation sites |
| lncRNAs | Hepatocellular carcinoma | Knockdown or overexpression in HCC models |
| GPR120 | Colitis and immune regulation | Knockout mice or T cell models |
Cancer and the Warburg effect
Many cancer cells reprogram glycolysis toward lactate production even in the presence of oxygen, a phenomenon known as the Warburg effect. Transcriptional regulators such as SIX1 promote this switch by upregulating glycolytic genes, supporting proliferation and survival. In bladder urothelial carcinoma, tumor aerobic glycolysis contributes to drug resistance, highlighting the clinical importance of glycolytic regulation. Long non-coding RNAs further modulate aerobic glycolysis in hepatocellular carcinoma, suggesting additional therapeutic targets.
Metabolic liver disease
The liver is central to glucose homeostasis, and dysregulation of glycolysis and gluconeogenesis contributes to metabolic disorders such as diabetes and fatty liver disease. Hormonal and nutritional signals that normally balance these pathways can become impaired, leading to hyperglycemia or altered lipid metabolism. Studying GO:0006110 in hepatocytes is therefore relevant to understanding and treating metabolic disease.
Developmental disorders and signaling
Glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling, linking metabolic state to embryonic patterning. Perturbations in this metabolic control could theoretically contribute to developmental abnormalities, although direct evidence in human disease requires further study. This area represents an emerging intersection of metabolism and developmental biology.
Inflammation and immune regulation
GPR120 inhibits colitis through regulation of CD4+ T cell interleukin 10 production, indicating that metabolic and inflammatory signaling are interconnected. While this study focuses on immune regulation, it underscores how metabolic pathways can influence inflammatory disease. Glycolytic regulation in immune cells is an active area of research.
From regulation of glycolysis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for glycolysis? | CRISPR knockout in cell lines [2,5] |
| Does a specific acetylation site regulate enzyme activity? | Point mutation knock-in of the target residue |
| Does overexpression of a transcription factor drive Warburg effect? | CRISPR activation or cDNA overexpression |
| Can a tagged glycolytic enzyme be tracked in live cells? | Tagged knock-in (e.g., GFP) |
| Which lncRNAs regulate aerobic glycolysis? | CRISPR library screening with metabolic readouts |
| Does glycolytic flux influence developmental signaling? | Knockout or overexpression in stem cell models |
How to Study the regulation of glycolysis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of glycolytic genes | Identifying transcriptional regulators [3,5] |
| Seahorse assay | Extracellular acidification rate (glycolysis) | Measuring glycolytic flux in cancer cells |
| Lactate assay | Lactate production | Assessing Warburg effect |
| Western blot | Protein abundance and modification | Detecting acetylation of PKM/PEPCK |
| Mass spectrometry | Post-translational modifications | Mapping acetylation sites |
| CRISPR screen | Gene essentiality or reporter activity | Discovering glycolytic regulators |
| qPCR | mRNA expression | Validating changes in glycolytic genes |
| Metabolomics | Intracellular metabolite levels | Profiling pathway intermediates |
Transcriptional profiling of glycolytic genes
RNA-seq and quantitative PCR can measure expression of glycolytic enzymes and regulators following genetic or environmental perturbations. This approach has been used to identify SIX1 target genes in cancer and to characterize lncRNA-mediated regulation in hepatocellular carcinoma [3,5]. Combining transcriptomics with pathway analysis helps annotate genes under GO:0006110.
Metabolic flux assays
Seahorse extracellular flux analysis and lactate production assays measure glycolytic rate and can reveal changes in pathway activity. Such assays are standard for studying the Warburg effect and drug resistance in cancer cells. They provide functional validation of regulatory mechanisms identified by genetic screens.
Post-translational modification analysis
Mass spectrometry and immunoblotting with modification-specific antibodies can detect acetylation or other modifications on glycolytic enzymes such as PKM and PEPCK. Site-directed mutagenesis combined with activity assays can test the functional impact of these modifications.
CRISPR screening and functional genomics
Pooled CRISPR knockout or activation screens coupled with metabolic readouts can systematically identify regulators of glycolysis. This strategy is powerful for discovering lncRNAs or transcription factors that modulate aerobic glycolysis in cancer. Bioinformatics analysis of screen hits can prioritize candidates for validation.
How CRISPR Can Be Used to Study GO:0006110 regulation of glycolysis
Knockout
CRISPR knockout of candidate regulators such as SIX1 or LDHA can test their requirement for glycolytic flux and cancer cell proliferation [2,3]. Knockout models are also used to study lncRNA function in hepatocellular carcinoma. These experiments provide causal evidence linking a gene to GO:0006110.
Point Mutation
Point mutations can be introduced into glycolytic enzymes to mimic or abolish post-translational modifications, such as acetylation sites on PKM or PEPCK. This allows precise testing of how specific residues affect enzyme activity and pathway flux. Such models are valuable for dissecting molecular mechanisms within GO:0006110.
Knock-in
Knock-in of tagged versions of glycolytic enzymes or reporters enables live-cell imaging and tracking of protein localization and dynamics. Tagged knock-in models can also be used to study adaptive regulation of glucose transport and glycolysis. These tools complement functional assays by providing spatial and temporal information.
Overexpression
CRISPR activation or cDNA overexpression can drive expression of transcription factors like SIX1 or glycolytic enzymes to induce the Warburg effect. Overexpression models are useful for testing sufficiency of a candidate regulator in promoting glycolysis. They can also be combined with metabolic inhibitors to study drug resistance.
How EDITGENE Supports regulation of glycolysis Research
Researchers studying regulation of glycolysis-related genes often need to determine whether a candidate gene is causally involved in modulating glycolytic flux, rather than merely correlated with it. CRISPR-based genome editing provides the tools to establish such causality through precise knockout, point mutation, knock-in and overexpression models. EDITGENE offers a comprehensive suite of services to support these investigations, from custom cell line generation to library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for regulation of glycolysis research.
Frequently Asked Questions About regulation of glycolysis
What is GO:0006110 regulation of glycolysis?
GO:0006110 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of glycolysis, the conversion of glucose to pyruvate.
What genes are involved in regulation of glycolysis?
Key genes include SIX1, PKM, PEPCK, LDHA, and various lncRNAs, as well as signaling components such as Nodal and Wnt [3,4,5,8].
How is glycolysis regulated in cancer?
Cancer cells often upregulate glycolysis via transcription factors like SIX1 and hypoxia-inducible factors, and this rewiring supports drug resistance [2,3].
What is the Warburg effect?
The Warburg effect is the observation that cancer cells preferentially produce energy through glycolysis and lactate fermentation even in the presence of oxygen.
How can CRISPR be used to study regulation of glycolysis?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes that regulate glycolytic flux [2,4,5].
What are the main mechanisms regulating glycolysis?
Transcriptional control, post-translational modifications such as acetylation, allosteric feedback, and hormonal signals in liver [1,3,4].
Which enzymes are rate-limiting in glycolysis?
Hexokinase, phosphofructokinase and pyruvate kinase are key regulatory enzymes, with PKM subject to acetylation.
How does the liver regulate glycolysis?
The liver responds to insulin and glucagon to switch between glycolysis and gluconeogenesis, maintaining blood glucose homeostasis.
Can glycolytic activity affect development?
Yes, glycolytic activity can instruct germ layer proportions through regulation of Nodal and Wnt signaling.
What methods are used to study regulation of glycolysis?
RNA-seq, Seahorse flux analysis, lactate assays, Western blot, mass spectrometry and CRISPR screens are commonly used [2,3,4,5].
Conclusion
GO:0006110 regulation of glycolysis encompasses a diverse set of mechanisms that control flux through the glycolytic pathway, from transcriptional regulation by SIX1 to post-translational modification of PKM and PEPCK [3,4]. These regulatory layers are critical for liver glucose homeostasis, cancer metabolism and developmental signaling [1,2,8]. Understanding them offers opportunities for therapeutic intervention in cancer and metabolic disease [2,5]. CRISPR-based models are indispensable for establishing causal roles of glycolytic regulators. By combining knockout, point mutation, knock-in and overexpression strategies with metabolic and transcriptomic readouts, researchers can dissect the complex regulation of glycolysis in health and disease [2,4,5].
References
- 1. Han HS et al.. 2016. Regulation of glucose metabolism from a liver-centric perspective.. Exp Mol Med 48(3):e218 PMID: 26964834
- 2. Weng C et al.. 2025. Regulation of drug resistance in bladder urothelial carcinoma by tumor aerobic glycolysis.. J Transl Med 24(1):85 PMID: 41390421
- 3. Li L et al.. 2018. Transcriptional Regulation of the Warburg Effect in Cancer by SIX1.. Cancer Cell 33(3):368-385.e7 PMID: 29455928
- 4. Xiong Y et al.. 2011. Regulation of glycolysis and gluconeogenesis by acetylation of PKM and PEPCK.. Cold Spring Harb Symp Quant Biol 76:285-9 PMID: 22096030
- 5. Huang Q et al.. 2024. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).. Oncol Rep 51(6) PMID: 38666534
- 6. Toyoda Y et al.. 2015. Adaptive regulation of glucose transport, glycolysis and respiration for cell proliferation.. Biomol Concepts 6(5-6):423-30 PMID: 26418646
- 7. Yang W et al.. 2022. GPR120 Inhibits Colitis Through Regulation of CD4(+) T Cell Interleukin 10 Production.. Gastroenterology 162(1):150-165 PMID: 34536451
- 8. Stapornwongkul KS et al.. 2025. Glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling.. Cell Stem Cell 32(5):744-758.e7 PMID: 40245870
